JAGSNPHARM investors check their stop-losses as it underperforms
19 Jul, 20197 min read
JAGSNPHARM underperformed today. On a longer term basis, investors in JAGSONPAL PHARMACEUTICALS made +0.1% per day. Friday's performance of -0.63% was a significant underperformance compared to it's daily average.
Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Symbol
Price
{{retType}}
|
Tr.
{{detail.symbol}}
{{detail.close}}
{{detail.priceChange}}
{{detail.pctChange}}%
{{detail.name}}
{{detail.trend}}
Share with friends 
